# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001731122-21-001498
Filing Date
2021-09-13
Accepted
2021-09-13 07:19:22
Documents
45
Period of Report
2021-09-13
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 8-K | e3088_8-k.htm | 8-K | 20786
2 | EXHIBIT 99.1 | e3088_ex99-1.htm | EX-99.1 | 39545
3 | GRAPHIC | ex99_1-001.jpg | GRAPHIC | 505526
4 | GRAPHIC | ex99_1-002.jpg | GRAPHIC | 443788
5 | GRAPHIC | ex99_1-003.jpg | GRAPHIC | 312946
6 | GRAPHIC | ex99_1-004.jpg | GRAPHIC | 305697
7 | GRAPHIC | ex99_1-005.jpg | GRAPHIC | 156378
8 | GRAPHIC | ex99_1-006.jpg | GRAPHIC | 303839
9 | GRAPHIC | ex99_1-007.jpg | GRAPHIC | 305935
10 | GRAPHIC | ex99_1-008.jpg | GRAPHIC | 304858
11 | GRAPHIC | ex99_1-009.jpg | GRAPHIC | 380267
12 | GRAPHIC | ex99_1-010.jpg | GRAPHIC | 286907
13 | GRAPHIC | ex99_1-011.jpg | GRAPHIC | 245492
14 | GRAPHIC | ex99_1-012.jpg | GRAPHIC | 182870
15 | GRAPHIC | ex99_1-013.jpg | GRAPHIC | 349975
16 | GRAPHIC | ex99_1-014.jpg | GRAPHIC | 296650
17 | GRAPHIC | ex99_1-015.jpg | GRAPHIC | 263249
18 | GRAPHIC | ex99_1-016.jpg | GRAPHIC | 337798
19 | GRAPHIC | ex99_1-017.jpg | GRAPHIC | 276496
20 | GRAPHIC | ex99_1-018.jpg | GRAPHIC | 166785
21 | GRAPHIC | ex99_1-019.jpg | GRAPHIC | 300352
22 | GRAPHIC | ex99_1-020.jpg | GRAPHIC | 401526
23 | GRAPHIC | ex99_1-021.jpg | GRAPHIC | 245059
24 | GRAPHIC | ex99_1-022.jpg | GRAPHIC | 247012
25 | GRAPHIC | ex99_1-023.jpg | GRAPHIC | 267280
26 | GRAPHIC | ex99_1-024.jpg | GRAPHIC | 198051
27 | GRAPHIC | ex99_1-025.jpg | GRAPHIC | 203013
28 | GRAPHIC | ex99_1-026.jpg | GRAPHIC | 166921
29 | GRAPHIC | ex99_1-027.jpg | GRAPHIC | 171851
30 | GRAPHIC | ex99_1-028.jpg | GRAPHIC | 176966
31 | GRAPHIC | ex99_1-029.jpg | GRAPHIC | 305854
32 | GRAPHIC | ex99_1-030.jpg | GRAPHIC | 284402
33 | GRAPHIC | ex99_1-031.jpg | GRAPHIC | 416450
34 | GRAPHIC | ex99_1-032.jpg | GRAPHIC | 305569
35 | GRAPHIC | ex99_1-033.jpg | GRAPHIC | 239341
36 | GRAPHIC | ex99_1-034.jpg | GRAPHIC | 292741
37 | GRAPHIC | ex99_1-035.jpg | GRAPHIC | 277481
38 | GRAPHIC | ex99_1-036.jpg | GRAPHIC | 430943
39 | GRAPHIC | ex99_1-037.jpg | GRAPHIC | 308758
40 | GRAPHIC | ex99_1-038.jpg | GRAPHIC | 291738
41 | GRAPHIC | ex99_1-039.jpg | GRAPHIC | 270193
42 | GRAPHIC | ex99_1-040.jpg | GRAPHIC | 315095
43 | GRAPHIC | ex99_1-041.jpg | GRAPHIC | 426005
44 | GRAPHIC | ex99_1-042.jpg | GRAPHIC | 372610
45 | GRAPHIC | ex99_1-043.jpg | GRAPHIC | 415625
| Complete submission text file | 0001731122-21-001498.txt |  | 17635223

Mailing Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163
Business Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

EIN.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-37606 | Film No.: 211248615
SIC: 8731 Services-Commercial Physical & Biological Research